Drug Shortage Report for AURALGAN

Last updated on 2022-02-02 History
Report ID 149033
Drug Identification Number 02332477
Brand name AURALGAN
Common or Proper name BENZOCAINE
Company Name PALADIN LABS INC.
Market Status MARKETED
Active Ingredient(s) ANTIPYRINE BENZOCAINE
Strength(s) 54MG 14MG
Dosage form(s) SOLUTION
Route of administration OTIC OTIC
Packaging size 14mL
ATC code S02DA
ATC description OTHER OTOLOGICALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-02
Estimated end date 2022-08-01
Actual end date
Shortage status Actual shortage
Updated date 2022-02-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 100 BLVD ALEXIS-NIHON, SUITE 600
SAINT-LAURENT, QUEBEC
CANADA H4M 2P2
Company contact information 1-866-340-1112 paladincs@endo.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-02-02 French Compare
v11 2022-02-02 English Compare
v10 2022-02-02 French Compare
v9 2022-02-02 English Compare
v8 2022-01-14 French Compare
v7 2022-01-14 English Compare
v6 2021-12-28 French Compare
v5 2021-12-28 English Compare
v4 2021-12-14 French Compare
v3 2021-12-14 English Compare
v2 2021-11-10 French Compare
v1 2021-11-10 English Compare

Showing 1 to 12 of 12